Dauch Corporation (NYSE: AXL) details new London share listing move

Rhea-AI Filing Summary

Dauch Corporation filed an 8-K describing the admission of its common stock to the equity shares (international commercial companies secondary listing) category of the Official List of the U.K. Financial Conduct Authority and to trading on the main market for listed securities of London Stock Exchange plc.

The London listing is being made in connection with the previously disclosed acquisition of the entire issued and to be issued share capital of Dowlais Group plc, a public limited company incorporated in England and Wales. The company released an announcement through the Regulatory News Service in London, which is furnished as Exhibit 99.1.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 02/04/2026 - 08:25 AM Learn about SEC filing dates

FAQ

What did Dauch Corporation (AXL) announce in this 8-K filing?

Dauch Corporation reported that its common stock has been admitted to the Official List of the U.K. Financial Conduct Authority and to trading on the main market of London Stock Exchange plc, with further details provided in an accompanying Regulatory News Service announcement.

How is the London listing related to Dauch Corporation’s (AXL) business combination?

The London listing of Dauch Corporation’s common stock is connected to its previously disclosed business combination to acquire the entire issued and to be issued share capital of Dowlais Group plc, aligning the company’s shares with Dowlais’s U.K. market presence.

What is Dowlais Group plc in Dauch Corporation’s (AXL) 8-K disclosure?

Dowlais Group plc is a public limited company incorporated in England and Wales whose entire issued and to be issued share capital Dauch Corporation plans to acquire, as referenced in the business combination linked to the new London Stock Exchange listing.

Where can investors read the full Dauch Corporation (AXL) RNS announcement?

The full Regulatory News Service announcement about Dauch Corporation’s London listing and related business combination is furnished as Exhibit 99.1 to the 8-K, and is incorporated by reference in the filing for more detailed information.

What forward-looking information does Dauch Corporation (AXL) highlight in this filing?

Dauch Corporation notes that the filing contains forward-looking statements about the business combination’s effects, including possible impacts on business relationships, operating results, future expenditures, revenues, synergies, financial condition, and regulatory effects, all subject to risks described in its periodic SEC reports.

false 0001062231 0001062231 2026-02-04 2026-02-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): February 4, 2026

DAUCH CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

1-14303		38-3161171
(Commission File Number)		(IRS Employer Identification No.)
One Dauch Drive, Detroit, Michigan		48211-1198
(Address of Principal Executive Offices)		(Zip Code)

(313) 758-2000

(Registrant's Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AXL		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01. Other Events

On February 4, 2026, Dauch Corporation, a Delaware corporation (the “Company”), released, via the Regulatory News Service in London, an announcement (the “RNS Announcement”) regarding the admission of shares of the Company’s common stock, par value $0.01 per share, to the equity shares (international commercial companies secondary listing) category of the Official List of the U.K. Financial Conduct Authority (the “FCA”) and to trading on the main market for listed securities of London Stock Exchange plc in connection with the previously disclosed terms of the Company’s acquisition (the “Business Combination”) of the entire issued and to be issued share capital of Dowlais Group plc, a public limited company incorporated in England and Wales (“Dowlais”).

A copy of the RNS Announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No.		Description
99.1		RNS Announcement, dated February 4, 2026.
104		Cover Page Interactive Data File (formatted in Inline XBRL)

Cautionary Statement Concerning Forward-Looking Statements

This Current Report on Form 8-K, and the documents incorporated by reference into this Current Report on Form 8-K, contain statements concerning the Company’s expectations, beliefs, plans, objectives, goals, strategies, and future events or performance, including, but not limited to, certain statements related to (i) adverse effects on the market price of the Company’s or Dowlais’s operating results; (ii) the effect of the announcement or completion of the Business Combination on the Company’s or Dowlais’s business relationships, operating results and business generally; (iii) future capital expenditures, expenses, revenues, economic performance, synergies, financial conditions, market growth, dividend policy, losses and future prospects; (iv) business and management strategies and the expansion and growth of the operations of the Company or the Dowlais; and (v) the effects of government regulation on the business of the Company or Dowlais. Such statements are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 and relate to trends and events that may affect the Company’s future financial position and operating results. The terms such as “will,” “may,” “could,” “would,” “plan,” “believe,” “expect,” “anticipate,” “intend,” “project,” “target,” and similar words or expressions, as well as statements in future tense, are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or the Company’s management’s good faith belief as of that time with respect to future events and are subject to risks and may differ materially from those expressed in or suggested by the forward-looking statements. These risks and uncertainties related to the Company include factors detailed in the reports the Company files with the Securities and Exchange Commission, including those described under “Risk Factors” in its most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. It is not possible to foresee or identify all such factors and the Company makes no commitment to update any forward-looking statement or to disclose any facts, events or circumstances after the date hereof that may affect the accuracy of any forward-looking statement.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned, hereunto duly authorized. 

	DAUCH CORPORATION
Date: February 4, 2026	By:	/s/ Christopher J. May
		Christopher J. May
		Executive Vice President & Chief Financial Officer